By Rachel Slajda ( January 25, 2013, 6:46 PM EST) -- The Food and Drug Administration announced Friday that it has approved the first over-the-counter treatment for overactive bladder in women, a transdermal patch marketed by Merck, two months after an advisory panel voted against making the treatment available without a prescription because of safety concerns. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.